US Medicare eyes medicine reimbursement changes
This article was originally published in Scrip
Executive Summary
The US Medicare agency is seeking public comment on whether to issue national coverage determinations (NCD) for several medicines, including erythropoiesis-stimulating agents (ESAs) and bisphosphonates.